z-logo
open-access-imgOpen Access
Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance
Author(s) -
Erin Hinchcliff,
Anca Chelariu-Raicu,
Shan N. Westin
Publication year - 2020
Publication title -
current opinion in obstetrics and gynecology/current opinion in obstetrics and gynecology, with evaluated medline
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.786
H-Index - 73
eISSN - 1080-8256
pISSN - 1040-872X
DOI - 10.1097/gco.0000000000000678
Subject(s) - medicine , cancer research , clinical trial , synthetic lethality , dna repair , biology , genetics , dna
To highlight relevant strategies to overcome poly(ADP-ribose) polymerase (PARP) inhibitor resistance and present key clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here